Perioperative morbidity and mortality following transmyocardial laser revascularization  by Hughes, G.C. et al.
JACC Fehru;ir), 1¢,~)8 
AB,VI'KACI~ ,. i',,',,ttr .~I¢~A 
• Effective Regurgltant Orifice Area Correlates With 
Blomechanlcal Characteristics of Myxomstous 
Mltral Valve: Using Olrm:t QuanUfleatlon by 
Thrm~:lln~nslonsl Echocardiography 
CS Breburd~, I. Vessoly, AR  Brewer, NR Rathff. DM Co,grove, 
JD  Thomas, BP  Gnffin Th~ Cry/and Clime Foundation. Clev~tancl, OH, 
LiSA 
Structural abnorma t~es n valve tissue are though~ to be respons ble for mtra 
!cartel prolapse and regurgitall0n in myxomafous disease. We hypothesized 
that the size of the eflec~ve fegurglfant office am~ (ROA) correlates wrth 
~han lca!  p~operl,,es of mitre! tlasu~ e~cised at vatv~ repair 
M~tt~. '  We r~st fu{  ~ed the mitral valve prolapse using thfee-din~n. 
~,,~.~'t~ l @the (3~IE)= 3° rolatert~! I~lwtsltlons (TomTe¢) with a fransesophagea 
muttiplane pr~e in 8 ~ ~;'td~f~l~ recital vahm repair (age .59 ~; t3 yrs, 
3 M). ROA was measured by direct 3DE ptanimetry ,as valKtafed by us p, l .  
vtOusly. Failure stress represents tissue strength and was determm~.d ..f 
:~Onfre41ed repetitive stretchcng (IntF- I ~ ur.itufm tif~.o r~npk~ t~ol=t "le 
exc,sed vane. 
Results: Mean ROA by direct 3DE quantification was 0.69 ~. 029 cm'~ 
(range 03t - !  .08) and cowetated s=gnd¢.anfly with mean failure stress of 27h 
r 91 g/mr (range 176-404), (see g~aph); 
3OE y = .~2x*  t..12. 
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Conclusion Maximal effect~e onhce area correlates reversely w~th tadure 
stress O! exc~sed vak, e tissue sugges~ng in.doSe ,n tissue strenqlh with 
more severe regurgitation in myxomafous val~e disease 
Transmyocardial Laser Revascularization 
Tuesday .  March  31,  1998,  Noon-2 :00  p .m 
Georg ia  Wor ld  Congress  Center ,  West  Exh ib i t  Hall  Leve l  
P resentat ion  Hour :  Noon-1 :00  p .m.  
~ Intensified Medical  Therapy  and  Transmyocard ia l  
Laser Revascularization in the Management of 
End-Stage Coronary  Ar tery  D isease  
H. Nagele, W. R0d~ger. H.-M. Stubbe. ~pt. st Card~.c S~,fge@; Unwersdy 
Hamburg, Germany 
Background: There are growing numbers el angina patients not su~tabte for 
conventional revasculanzation procedures such as CABG or PTCA. Trans- 
myocardial laser revasculanzation (TMR) was introduced as a therapeutic 
option =n this condition However there is uncertainty when to use this method 
and how TMR affects medium- and long-term outcome. 
Methods: prospective follow-up of 124 pt. submitted for TMR with no 
possibility of conventional revasculanzation Final acceptance for TMR was 
only given after a 1-2 month thai penod with intensified a~itianginal therapy. 
Therapy changes were increased 6-blockers (45% prevs 67% post) ca2+ 
channel blockers (59% prevs 72% post), mols~domine (120,, prevs 94% post) 
and ACE mhlbitors 23% pro vs 56% post). 66 t53%) pts. can be managed 
with medical treatment only. 58 (4~,)  pts. undewvent pure TMR. Pts. were 
followed in our outclinic and outcome events weee compared with the log 
rank test. 
Results: Mean follow-up time was 1.5 + -0.8 years. Cardiac events and 
reinterventions occur at signiticantly lower rates m the medical vs 1he TMR 
group (table). CCS class at 1 year (1 7 vs 2.2) and 2 years (1 9 vs 2.5) was 
also slightly better in the medical group. Only one pt. crossed to TMR Overall 
Survival shows no significant difference. 
n LVEF Event  Event  Interv. Intcrv. Ahve Ahve 
tree ly free 2y free t y tree 2y 1 y 2y 
TMR 58 53% 53°0 40°© 75% 65",, 80"0 75"0 
Medical 66 41% 78% 58% 95 96 79% 68% 
p ~001 0.02 0.02 ~0001 - 0.001 ns n.s. 
Conclusion: Individual titration of medical therapy prevented the need for 
TMR ,n more than 50% o! cases wffh lower events and remtet~mP~ns dUrmQ 
fho hrst two f0ttow.up years. Surwval was stmdar c~e a lower LVEF ,~ me 
medic.at group TMR shouk3 onl~/be u~l  after f~!um of ietteesc/ma meO~..a| 
therapy 
• A©uto Effects of Heart Laser on l i chemlc  
MyP~snt lum 
N Hellion, K Bse, S Abe, MU Mohammed, T Sekka, Y Suglo, 
Y Shinozakl, Y Onlshl, E Tanaka, S. Hand~, H Nakazawa. H Men ~a~ 
Umv. /~'et~ra, Japan 
Background. The mechanism u! transmye~.'~.antta! revaSCuian,~af~a (TMR) 
has not been fully elucidated We evatualecl th~ acute effects of TMR, 
Mef~:  Tr,~eo times ot tsehemta for 2 mm was cmaled by llgafmg itle 
proximal of left anfenor discending artery (LAD) leawng 30 mm ottrrlermi~ton 
in five dogs, Ten to eleven transmurai holes wllh diameter st t rnm were 
emoted by using a CO~ laser (20-301oule) after the 1st isehemla. Regional 
blOOd flow dunng temporal =sehemia was meaSumcl w~lh mtcrospt~raS At 
fl'~ end o! 3 rd ischemla the 13eafi~l h~arta were rapKgy cro~s sect~o~i~l 
ar~ freeze clamped to v~suasze the two.dimensional d*stnbutton of NADH 
fluorescence 
I s zs CZ]pre TMR 
BBI post TMR 
° i; Is:i~hemicreg;on w~,~out TMR I¢ Is hi I= is NI hde5 
Endocardium Epicardium Nl:non ischemm re.an 
Resup.s Local myocardial flow was not altered by TMR (Figure) NADH 
fluorescence demon.strafed diffuse ischorma and did not show the drfference 
between the ,schemic regions with and without TMR holes 
Cortc/uslon TMR does not in ' t~ nlyocardial ischemia in acute phase 
~ - ~  Detection of Perioperative lachemla Following 
Transmyocard ia l  Laser  Revascular izat ion 
GC Hughes, K.P Landolfo, J,E, Lowe, R.B. Coleman, CL  Donovan Duke 
UmverS~y Medical Center, Durham, North Carohna, USA 
Background. Transmyocardlal laser revasculanzatmn (TMR) is an mves- 
tlgahonal therapy for coronary artery disease not amenable to tradmonal 
revasculanzatmn. Because clinical improvement following TMR is typically 
delayed, patTents (pts) are at increased risk for post-operative tsct,emtc 
events. The purpose ot thcs study was to define the range el c,reatine phos- 
phokstase (CPK) and CPK-MB enzyme elevation post-TMR and fo correlate 
these findings w:th clinical and EGG e..idence of ischemta. 
Methods: Senal total CPK and CPK-MB enzymes and 12 lead ECGs were 
obtained every 8 hours for 48 hours posf0peratwely in 20 pts undergmng 
TMR 
Results Among the 20 pts, 11 (55%) had transient ECG changes sue- 
gestive of ischemta (6 w, th ST elevation. 5 with ST depression) in the fh'st 48 
hours following TMR However, only 4 (20%) pts had angina or dinm...at sust~- 
clon for ischomia. Peak CPK-MB was significantly higher for pts with ischemlc 
ECGs (42 ± 35) compared to ptS with negative ECGs (9 ± 4, p = 0.01 ). IJke- 
w~se. there was a trend toward higher total peak CPK tot pts with compare0 
to those w~thout ischem,c ECGs (1703 ± 1373 vs 955 ~ 644). The elevation 
m CPK-MB did not correlate w~th the number of laser holes (F 2 = 0.2). 
Conc/usron: Routine measurement of CPK and MB isoenzymes and ECGs 
are warranted for diagnosis of penopera~e ischemia and myocardial tntaro- 
tien following TMR. as transient ischemia occurs frequently and is clinically 
silent in the maionty ot patients. 
• • •  Perioperative and Mortality Following Morbidity 
Transmyocard ia l  L , ser  Revascular izat ion 
G.C. Hughes, K.P. Landoito, J.E. Lowe, RB. Coleman. C.L. Donovan. Duke 
University Medical Center, Durham, North Carolina. USA 
B~.ckground This investigation was performed to assess the pen~erat~ve 
complications following transmyocardial laser revasCutanzation (TMR) in pa- 
tients (pts) with severe coronary artery disease ICAD). 
Methods: Between 9/95 and 7/97, 31 consecutive pts (mean age 60 z 
9 yrs. 12 women) v, qth inoperable CAD and class I11 or IV angina pectons 
underwent isolated TMR using an 800 W CO2 laser. None st the pts had 
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unstable symptoms preoperatively, Their medical records were reviewed for 
fatal and nonfatal adverse events, 
Results: Perioperatlve death occurred in 1 pt (3%) duo to cardiogenlc 
shook from acute myocardial Infarction (AMI), Perloperative morbidity in- 
eluded: 
Ca~lac Non-Cardiac 
Angina 10 (32%) Ronnl Failure 2 (Q%) 
AMI 2 (0%) CVA 1 (3%) 
CHF S (26%) 8epalel 1 (3%) 
Arrhythmla 4 (13%) Trsnaf,alon 6 (19%) 
Concluslorm: Psrloperstlva morlallty and noncardlec morbidity In pts with 
class III or IV angina pectorls undergoing Isolated TMR ts tow, Compared to 
conventional coronary artery bypass surgery, TMR pts are at higher risk for 
pedoperatlve cardiac event~, likely reflecting the lack of Immediate benefit 
from the procedure In the setting of severe CAD, These pie merit vlgllnnt 
surveillance for adverse cardiac events Dad aggressive medical management 
In the perioperetlve period, 
~ Clinical Experience With l 'renamyo©ardlal 
Rsvaseularlzatlon Util izing a Holmlum;¥AG Laser 
K,B, Allan, R,D, Dowltng, D,A, Helmansohn, E, Raltsma, L,T, Dldelot, 
C,J, She, at, St, Vincent Ho.~ltal, Indianapolis, Indlan~; Unlve~tty of 
Louisville, Louisville, Kenfuc~, U,~4 
~¢'/~ground: In the Unltod States. studies hove boon undo~ay since 1995 to 
assess the safety and efficacy o1 Tmnsmyocardtal ravascularlzatlon (TMR) 
u~lng e. holmlum:YAG later, 
Methods: TMR was pedormod in 42 patients with rafrsgtory angina who 
were not candidates for PTCA or CABG (mean age 62 • 11, range 38-79 
yeare), Patients had either Class IV angina (n = 23) or had unstable angina 
(n = lg) and were unwoanable from Intravenous nitroglycerin, Preoperative 
thallium studies Identified the extent and location of rever~lbte Ischomla, 
Operative exposure was via a Ilmltsd left anterior thoracotomy, An average 
of 45 ,-.t: 11 laser channels ware created with a mean operative time of 106 
38 minutes, 
Results: At three months follow.up (n = 23) mean angina class was 1.5 
:i: 0,1 (p < 0,001), nnd at six months follow-up (n = 11) moan angina class 
was 1,1 ± 0,1 (p < 0.002); versus 4,0 ± 0 at baseline. Mortality was 12% 
(5/42) with no late deaths, Complications Included ventdcular arrhythmlas 
12% (5/42), Intraeortlc balloon placement 12% (5/42), reoperatlon for chest 
wall hemorrhage 2% (1142), and respiratory failure requiring relntubatlon 2% 
(1142), Median postoperative length of stay was 5,5 ± 4.9 (range 1-25) days. 
Conclusion: Transmyooardtal ravascularizatlon with a Ho:YAG laser re, 
suits in a significant reduction in angina class and is beneficial in patients 
with refractory angina untroatable by conventional methods, 
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I 1"120"1S4'1 Outcome In Patients With Clinically Silent 
Coronary Artery Fistulae 
M.C, Sherwood, S. Rockenmachor, S,D. Colan. T, Geva, Children's 
Hospital, Boston, Massachusetts, Lahey Hitchcock Clinic, Manchester, New 
Hampshire, USA 
Background: With the advent of high resolution 2-D and color echo the de- 
tection rate of clinically silent coronary artery fistulae (CAF) has increased. 
Because the clinical significance and outcome of these CAF has not been de- 
tined, this study aims to determine the clinical significance of echo diagnosed, 
clinically silent CAE 
Methods: The echo, clinical, ECG. and angiogr'aphic findings and docu- 
mented follow-up of 31 patients, mean age 7.2 ~ 8,4 years (range 0.01.-39.9) 
at presentation, with an unsuspected echo finding of CAF (1986.-1997), were 
analyzed. Smusoids and small fistulae following tntracardiac surgery were 
excluded. 
Results: The indications for echo were known heart disease (n = 2), 
murmur (n = 23), cardiomegaly (n = 2). chest pain (n = 1), strider (n = 1), 
syncope (n = 1) and chest trauma (n = 1). Cardiac anomalies (n = 10) were 
ASD, VSD, bicuspid aortic valve, mild Ebstein's anomaly, coamtation LV 
aneurysm, and RA appendage hemangioma. CAF were detected with color 
Doppler In all patients. The origin was from the left coronary system (n = 27). 
dght coronary system (n = 3) and bllatsral (n = 1). The entry sites were the PA 
(n = 18), RV (n = 8), RA (n = 2) and LV (n = 3). The entire length of CAF was 
visualized in 14 patients. Anglogrsphy (n = 5) confirmed the echo findings (n 
= 2). and delineated the origin (n = 2) or entry point of CAF (n = 1), Follow.up 
was to mean age 8,; ± 8.4 years (range 0.3.-42,0). Spontaneous closure 
of CAF (n ,  7) occurred st mean age 6.8 ± 4.3 years (range 0,3-13.7), 
In 23 patients CAF persisted, without Intervention. All patients remained 
asymptomattc, with no adverse clinical events or ECG evidence of Ischomle 
at mean ego at follow.up of 9,3 ± 9.1 yearn (range 0,3-42,0), 
Conclusion: Based on thls experience there was no evidence that din. 
tcslly silent CAF that am diagnosed Incidentally by echo ere aoaoclatsd 
with adver,~e clinical outcomes, Conservative management of theme patients 
appears to I~o appmprlnts, 
~ Out©omes of  Aort ic Valve Stenoals Present ing In 
Neonates 
S, Bnrsm, B,W, McCfledle, R,M, Freedom, D Nykanen, The HasP. torSick 
Children, Univ, Of Tomn~ Canada 
/]net(ground; Management Of isolated aedic valve stenosis (AVS) mquffing 
intervention at age ~.3 me is controversial, We sought 1o define factors 
associated with outcomes after neonatal presentation, 
Mefhod~: From 1185 to 12/96, 62 infants presented with AVS at ,-3 me of 
age; 7 wore excluded due to significant mltrat valve abeomlalitres (4 died). 
Clinical, echo, hamoclynamic and ang;ogrephic, management and outcome 
data were obtained, 
Results: Median ago at presentation was 6cl, with only murrour in 30, 
signs of CHF in 20 and poor peduslen/sheck in 5 pts, Initial echo showed 
reduced LV function in 26%. with a moan peak instantaneous gradient of 69 
± 30 mmHg in those with normal function, There were 4 deaths (/%). all 
with poor function and before age 1,4 me. with survival thereafter of 92% 
(g5%cI, 85-.99,6%) up to age 11,9 yrs. Initial intervention was transcatbater 
dilation In 23 and surgical valvotomy in 20 pie, with 12 baying no inten'ention 
to date, Freedom from intervention for AVS was 69% at age 1 wk, 58% at 1 
me, 35% at 3 me, 29% at 1 yr and 19% at ago 5 yr, Addihonat intewentmns 
were mquirsd in 14 pts, Patients without poor pedusiontshock, normal LV 
function and peak instantaneous gradients <60 mmHg at presentation (n = 
19. Group I) vs, pts with poor function or initial gradients >60 mmHg (n = 36. 
Group II) had better survival (I-0 vs, 11--4 deaths), and longer freedom from 
intervention at age 1 wk (I-100% vs. 11-53%), 1 me (I-95% vs. 11-39%). and 6 
me (I-79% vs. 11-12%) (p = 0,0001). 
Conclusions: The majoflty of neonates presenting with AVS require inter- 
vention, although this may be safely delayed =n selected patients with lower 
initial gradients and good LV function. 
J 1120-156 J Course of  Right Ventricular Funct ion in Patients 
With Pu lmonary  Insuff iciency After Repair  o f  
Tetralogy ot  Fatter 
M,S, Schambarger, R,A. Hurwitz. Indiana Universi~. Indianapohs. IN, USA 
Background: Surgical repair of Tetralogy of Fagot (ToF) frequently results in 
pulmonary insufficiency (PI). Nevertheless, little information is available on 
the Ion9 term impact of PI on right ventrleular function. 
Methods: 21 patients with at least moderato PI alter repair of ToF were 
studied serially by radionuclide angiocardiography. The first (baseline) study 
was obtained a mean of 1.2 years (range 0.1 to 6.4) after surgery. The last 
study was podormed a mean of 10.2 years (range 4.6 to 16.9) after surgery. 
Results: The mean RVEF at baseline was 0.52 ~: 0.1 (normal: 0.53 -+- 
0.06; n,s.s). At the time of the last study the mean RVEF had decreased 
significantly to 0.45 ± 0.1 (p < 0.01). 
05 
RVEF 
0 Z 4 6 ~ ~,0 LZ H 
YEAP3 
At the last study, 7 patients (33%) had a RVEF <0A2, which is >2 
SD below our laboratory normal. Using 0.05 as our reproducibility factor for 
change in RVEF, 2 patients showed improvement in RVEF. 7 patients showed 
no change and 12 patients (57%) showed a decrease in RVEF. 
